Recombinant IL9 (Enokizumab Biosimilar) antibody
This Mammalian Cells Monoclonal antibody specifically detects IL9 (Enokizumab Biosimilar) in ELISA. It exhibits reactivity toward Human.
Catalog No. ABIN7487962
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 10 Business Days
Quick Overview for Recombinant IL9 (Enokizumab Biosimilar) antibody (ABIN7487962)
Target
IL9 (Enokizumab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This IL9 (Enokizumab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Enokizumab Biosimilar - Anti-IL9 mAb
-
Characteristics
- Antibody Type: IgG1-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG1 kappa
-
-
anti-IL9 (Enokizumab Biosimilar) antibody
Research Grade Reactivity: Human ELISA, FACS Host: Humanized Monoclonal unconjugated
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- IL9 (Enokizumab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
7F3com-2H2,MEDI-528
Recombinant monoclonal antibody to IL17A. Ixekizumab is a humanized monoclonal antibody used in the treatment of autoimmune diseases.
Target
-
You are here:
